Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alpha Cognition Inc (OP: ACOGF )

0.5500 +0.0270 (+5.16%)
Streaming Delayed Price Updated: 2:32 PM EDT, Jul 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Alpha Cognition Inc

< Previous 1 2 Next >
Epigenetics, Psychedelics and Stem Cell Therapy are Topics of the Life Sciences Virtual Investor Conference Launching This Thursday
Photo by Chris Montgomery on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... 
Via Benzinga
Alpha Cognition Announce Data from Pre-Clinical Study of ALPHA-1062 for Traumatic Brain Injury
From Alpha Cognition Inc.
Via Business Wire
Alpha Cognition Appoints Cedric O’Gorman, M.D., MBA as Chief Medical Officer
From Alpha Cognition Inc.
Via Business Wire
Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021
LOS ANGELES, CA / ACCESSWIRE / December 6, 2021 / The SNN Network Canada Virtual Event will take place on December 7-9, 2021, where 70 SmallCap, MicroCap and NanoCap public and private companies will... 
From Stock News Now
Via AccessWire
Alpha Cognition Reports Third Quarter of Fiscal 2021 Results
From Alpha Cognition Inc.
Via Business Wire
Alpha Cognition Inc. (TSX.V: ACOG) (OTCQB: ACOGF) Featured in Coverage of Investor Summit Group’s Q4 Virtual Event
Via Investor Brand Network
Alpha Cognition to Present at LD Micro Main Event
From Alpha Cognition Inc.
Via Business Wire
Alpha Cognition Provides CEO Update
From Alpha Cognition Inc.
Via Business Wire
Alpha Cognition Announces Formation and Members of Scientific Advisory Board and Investor Relations Agreements
From Alpha Cognition Inc.
Via Business Wire
Alpha Cognition Attracts New Investors as Future Leader in Growing Alzheimer's Disease Market
Image Provided By Unsplash The premier marketplace for early stage and developing companies approved the clinical stage biopharmaceutical company, Alpha Cognition Inc. (OTCQB:... 
Via Benzinga
Alpha Cognition, Focused on Neurodegenerative Diseases, CEO Clip Video
Vancouver, British Columbia--(Newsfile Corp. - September 11, 2021) - Alpha Cognition (TSXV: ACOG) (OTCQB: ACOGF) - CEO, Michael McFadden speaks... 
Via Newsfile
Alpha Cognition Announces the Acceptance of its US FDA Investigational New Drug Application (IND) for Lead Candidate, ALPHA-1062 for Mild to Moderate Alzheimer’s Disease
From Alpha Cognition Inc.
Via Business Wire
Alpha Cognition Reports Second Quarter of Fiscal 2021 Results
From Alpha Cognition Inc.
Via Business Wire
Alpha Cognition to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021
From Alpha Cognition Inc.
Via Business Wire
Alpha Cognition Receives Approval to Commence Trading on the OTCQB
From Alpha Cognition Inc.
Via Business Wire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.